别嘌醇与苯溴马隆对原发性高血压合并高尿酸血症患者有效降低血清尿酸水平的治疗策略——一项随机交叉研究（寺尾研究） - Suppr | 超能文献

相似文献

1

Therapeutic strategy for efficient reduction of serum uric acid levels with allopurinol versus benzbromarone in hyperuricemic patients with essential hypertension - A randomized crossover study (terao study).别嘌醇与苯溴马隆对原发性高血压合并高尿酸血症患者有效降低血清尿酸水平的治疗策略——一项随机交叉研究（寺尾研究）

Int J Cardiol. 2016 Dec 1;224:437-439. doi: 10.1016/j.ijcard.2016.09.073. Epub 2016 Sep 24.

2

Lesinurad: A Review in Hyperuricaemia of Gout.雷西纳德：痛风高尿酸血症的综述

Drugs Aging. 2017 May;34(5):401-410. doi: 10.1007/s40266-017-0461-y.

3

Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.苯溴马隆与别嘌醇相比在降低高尿酸血症患者血清尿酸水平方面的疗效。

J Med Assoc Thai. 2002 Jun;85 Suppl 1:S40-7.

4

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.通过降低血清尿酸水平的能力，使用别嘌醇来减缓肾脏疾病的进展。

Am J Kidney Dis. 2006 Jan;47(1):51-9. doi: 10.1053/j.ajkd.2005.10.006.

5

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.非布司他对高尿酸血症合并高血压患者动态血压的影响：一项 2 期随机安慰剂对照研究。

J Am Heart Assoc. 2017 Nov 4;6(11):e006683. doi: 10.1161/JAHA.117.006683.

6

Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.黄嘌呤氧化酶抑制剂对高尿酸血症高血压患者肾功能和血压的影响。

Hypertens Res. 2016 Aug;39(8):593-7. doi: 10.1038/hr.2016.37. Epub 2016 Apr 14.

7

[Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects].[特发性高尿酸血症的药物治疗——介绍、剂量及副作用]

Nihon Rinsho. 2003 Jan;61 Suppl 1:202-8.

8

[Effectiveness and tolerance of long-term uricosuric treatment].[长期尿酸排泄促进治疗的有效性和耐受性]

Z Gesamte Inn Med. 1990 Dec 1;45(23):719-20.

9

(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.(E)-2-(4-溴苯基)-1-(2,4-二羟基苯基)乙酮肟通过对 XOD 和 URAT1 的双重抑制作用，是治疗高尿酸血症的潜在治疗药物。

Biomed Pharmacother. 2017 Feb;86:88-94. doi: 10.1016/j.biopha.2016.12.002. Epub 2016 Dec 9.

10

Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.苯溴马隆和非布司他对高尿酸血症患者内皮功能影响的随机、开放标签、交叉对照比较

Int Heart J. 2020 Sep 29;61(5):984-992. doi: 10.1536/ihj.20-114. Epub 2020 Sep 12.

引用本文的文献

1

The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout.非布司他与苯溴马隆低剂量联合用药与单药治疗痛风的疗效比较。

Front Med (Lausanne). 2025 Feb 7;12:1469879. doi: 10.3389/fmed.2025.1469879. eCollection 2025.

2

Quantitative structure-activity relationship study of amide derivatives as xanthine oxidase inhibitors using machine learning.基于机器学习的酰胺衍生物作为黄嘌呤氧化酶抑制剂的定量构效关系研究

Front Pharmacol. 2023 Jun 29;14:1227536. doi: 10.3389/fphar.2023.1227536. eCollection 2023.

3

Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.